企業プロフィール
Aurinia Pharmaceuticals Inc 株価・ニュース・カタリスト
- ティッカー:
- AUPH
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Canada
株価パフォーマンス
15.29 USD (-1.16%)
終値
最終更新: 2026年8月17日
1.98B USD
時価総額
株価変動の要因
As of Aug 17, 2026, AUPH closed down 1.16% at $15.29. No new same-company headline was identified in the current news window.
企業概要
事業概要
Aurinia Pharmaceuticals is a biopharmaceutical company focused on autoimmune disease, especially kidney-related immune disorders. Its story combines commercial products with the challenge of maintaining growth in a specialty immunology market.
所在地とセクター分類
Aurinia is headquartered in Canada and listed on NASDAQ. It sits in specialty biopharma with immunology and renal exposure.
ビジネスモデルの特徴
The company depends on product sales, market access, and the ability to manage a focused franchise in autoimmune disease. Investors watch revenue, label strategy, and pipeline or portfolio updates.
バイオ業界での位置付け
Aurinia occupies a durable specialty-immunology niche within biotech. It has commercial grounding, but the stock remains sensitive to execution and franchise durability.
今後のカタリスト
- Aurinia’s catalysts are Lupkynis execution, lupus-nephritis adoption, and any label or commercial update that broadens the franchise. The market will care about whether growth stays steady.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。